mwilkin8, can you find out if this report was from Linda Ong? Why would she "continue to apply an 85% probability-weighting to reflect ATC’s Phase 3 stage of development" There is a huge difference between 21 days and 24 weeks" ??? remember.. "all HIV/AIDS drugs to enter phase III trials having been granted approval to date"
I am very interested to hear what Graeme Wald, biotech analyst from Wilson HTM has to say. I'm waiting!
AVX Price at posting:
0.0¢ Sentiment: Buy Disclosure: Not Held